New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed)

Funding Opportunity PA-19-049 from the NIH Guide for Grants and Contracts. The development of more effective means for diagnosing and treating heart, lung, blood, and sleep (HLBS) disorders is often aided bya detailed understanding of normal biology, specifically the nature and operations of the molecular systems and cells that are affected by those diseases. ?Areas of?r?e?s?e?a?r?c?h? ?i?n?t?e?r?e?s?t?include? ?s?t?u?d?i?e?s? ?o?f? ?f?u?n?d?a?m?e?n?t?a?l? ?p?r?o?c?e?s?s?e?s? ?t?h?a?t?explain resilience the capability of some individuals to maintain or restore normal function despite aging or exposurethat causes disease in others.This Program Announcement FOA will support pilot studies by R01-funded investigators in areas of research that advance high priority studies of normal biology and resilience as described by Objective 1 of the NHLBI Strategic Vision.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding